title: Activation of p-38alpha MAPK contributes to neuronal hyperexcitability in caudal regions remote from spinal cord injury.
abstract: In the present study, we examined whether activation of p-38alpha MAPK modulates mechanical allodynia and neuronal hyperexcitability, and if propentofylline (PPF, a glial modulator) modulates specifically localized activated p-38alpha MAPK expression in caudal regions remote from a low thoracic hemisection injury in rats. T13 spinal hemisection produces bilateral mechanical allodynia in hindpaws with evoked (in response to mechanical stimuli) neuronal hyperexcitability in lumbar spinal wide dynamic range (WDR) neurons compared to sham controls. The mechanical allodynia and the evoked activity of WDR neurons is attenuated by intrathecal and topical administration of SB203580, an inhibitor of p-38 MAPK activation, dose dependently (p<0.05); however, the spontaneous activity showed no significant differences compared to sham controls. After T13 spinal hemisection, significantly increased phosphorylated (activated form) p-38alpha MAPK expression was present in both superficial and deep dorsal horn neurons as well as in microglia, but not in astrocytes, in the lumbar spinal cord compared to sham controls (p<0.05). Intrathecal application of PPF significantly attenuated the expression of phosphorylated p-38alpha MAPK in superficial dorsal horn neurons (10 mM) and in microglia (1 and 10 mM) in the lumbar spinal cord compared to the hemisection group (p<0.05). In conclusion, our present data demonstrate that activated neuronal and microglial, but not astrocytic, p-38alpha MAPK contributes to the maintenance of neuronal hyperexcitability in caudal regions following spinal cord injury.
authors.affiliation: Department of Neuroscience, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-1043, USA. ysgwak@utmb.edu
authors.forename: Young S
authors.initials: YS
authors.lastname: Gwak
authors.forename: Geda C
authors.initials: GC
authors.lastname: Unabia
authors.forename: Claire E
authors.initials: CE
authors.lastname: Hulsebosch
mesh_terms: D000818:Animals; D001253:Astrocytes / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D004195:Disease Models, Animal; D004789:Enzyme Activation / Q000187:drug effects / Q000502:physiology*; D005911:Gliosis / Q000188:drug therapy / Q000201:enzymology / Q000503:physiopathology; D006930:Hyperalgesia / Q000188:drug therapy / Q000201:enzymology / Q000503:physiopathology; D008297:Male; D017628:Microglia / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D009474:Neurons / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology; D009475:Neurons, Afferent / Q000201:enzymology / Q000473:pathology; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D017207:Rats, Sprague-Dawley; D011984:Sensory Receptor Cells / Q000201:enzymology / Q000473:pathology; D013116:Spinal Cord / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology; D013119:Spinal Cord Injuries / Q000188:drug therapy / Q000201:enzymology* / Q000503:physiopathology; D016896:Treatment Outcome; D014970:Xanthines / Q000494:pharmacology / Q000627:therapeutic use; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism*
chemical_list: D018696:Neuroprotective Agents; D014970:Xanthines; C032114:propentofylline; D048051:p38 Mitogen-Activated Protein Kinases
references.citation: J Neurotrauma. 2002 Jan;19(1):23-42
references.pmid: 11852976
references.citation: Curr Opin Investig Drugs. 2008 Jul;9(7):726-34
references.pmid: 18600578
references.citation: Neuroscience. 2009 Jul 7;161(3):895-903
references.pmid: 19332108
references.citation: J Comp Neurol. 2005 Aug 15;489(1):1-10
references.pmid: 15977163
references.citation: Neuropeptides. 2005 Oct;39(5):485-94
references.pmid: 16176831
references.citation: Pain. 2001 Sep;93(3):201-205
references.pmid: 11514078
references.citation: J Neurotrauma. 2004 Aug;21(8):983-93
references.pmid: 15318998
references.citation: Exp Neurol. 1999 Oct;159(2):538-44
references.pmid: 10506525
references.citation: Pain. 2003 Aug;104(3):655-664
references.pmid: 12927638
references.citation: J Neurosci. 2003 Oct 1;23(26):8881-92
references.pmid: 14523090
references.citation: J Comp Neurol. 1952 Jun;96(3):414-95
references.pmid: 14946260
references.citation: Exp Neurol. 2008 Aug;212(2):337-47
references.pmid: 18511041
references.citation: Brain Res. 2000 Mar 17;859(1):72-82
references.pmid: 10720616
references.citation: J Neurosci. 2002 Sep 1;22(17):7526-35
references.pmid: 12196576
references.citation: J Neurochem. 2005 Nov;95(4):998-1014
references.pmid: 16219025
references.citation: Exp Neurol. 2008 Nov;214(1):6-9
references.pmid: 18708053
references.citation: J Neuroimmunol. 1999 Jan 1;93(1-2):182-93
references.pmid: 10378882
references.citation: Brain Res. 2002 Feb 8;927(1):104-10
references.pmid: 11814437
references.citation: J Neurochem. 2005 May;93(4):943-52
references.pmid: 15857397
references.citation: Exp Neurol. 2005 Sep;195(1):236-43
references.pmid: 16004983
references.citation: J Neurotrauma. 2001 Sep;18(9):947-56
references.pmid: 11565605
references.citation: Eur J Neurosci. 2005 Nov;22(10):2431-40
references.pmid: 16307586
references.citation: J Neurosci Methods. 1994 Jul;53(1):55-63
references.pmid: 7990513
references.citation: J Neurophysiol. 1986 Aug;56(2):308-27
references.pmid: 3760923
references.citation: Pain. 2008 Aug 31;138(2):410-422
references.pmid: 18353556
references.citation: Exp Neurol. 2008 Oct;213(2):257-67
references.pmid: 18590729
references.citation: J Comp Neurol. 2006 Feb 1;494(4):578-94
references.pmid: 16374800
references.citation: Brain Res. 1998 Nov 23;812(1-2):97-104
references.pmid: 9813261
references.citation: Neurobiol Dis. 2001 Feb;8(1):1-10
references.pmid: 11162235
references.citation: Brain Res Mol Brain Res. 2005 Aug 18;138(2):244-55
references.pmid: 15922485
references.citation: J Physiol. 1972 Sep;225(2):275-96
references.pmid: 5074387
references.citation: J Neuroimmunol. 2008 Jul 31;198(1-2):113-20
references.pmid: 18547654
references.citation: Pain. 2005 Mar;114(1-2):149-59
references.pmid: 15733640
references.citation: Proc Natl Acad Sci U S A. 1974 Apr;71(4):1188-92
references.pmid: 4524631
references.citation: J Neurosci. 2006 Apr 19;26(16):4308-17
references.pmid: 16624951
references.citation: Adv Physiol Educ. 2002 Dec;26(1-4):238-55
references.pmid: 12443996
references.citation: Exp Neurol. 2006 Jun;199(2):397-407
references.pmid: 16478624
references.citation: Physiol Rev. 1999 Jan;79(1):143-80
references.pmid: 9922370
references.citation: J Pharmacol Exp Ther. 2001 Jun;297(3):1210-7
references.pmid: 11356948
references.citation: Brain Behav Immun. 2007 Feb;21(2):238-46
references.pmid: 16949251
references.citation: J Neurosci. 2008 Dec 3;28(49):13173-83
references.pmid: 19052208